IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.766
NA - Nord America 4.526
AS - Asia 2.007
SA - Sud America 837
AF - Africa 410
OC - Oceania 5
Totale 12.551
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.351
RU - Federazione Russa 4.041
SG - Singapore 1.093
BR - Brasile 698
CI - Costa d'Avorio 339
VN - Vietnam 236
CN - Cina 193
HK - Hong Kong 154
IT - Italia 136
DE - Germania 119
GB - Regno Unito 98
CA - Canada 95
IN - India 70
AR - Argentina 58
NL - Olanda 52
MX - Messico 50
PL - Polonia 42
BD - Bangladesh 41
AT - Austria 34
CZ - Repubblica Ceca 32
IQ - Iraq 32
JP - Giappone 32
ES - Italia 31
ZA - Sudafrica 30
IE - Irlanda 29
LT - Lituania 29
FI - Finlandia 27
SE - Svezia 24
TR - Turchia 24
EC - Ecuador 22
ID - Indonesia 21
UA - Ucraina 20
PK - Pakistan 15
EG - Egitto 14
CO - Colombia 13
SA - Arabia Saudita 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
FR - Francia 10
VE - Venezuela 10
BE - Belgio 9
UZ - Uzbekistan 9
UY - Uruguay 8
MA - Marocco 7
PE - Perù 7
AZ - Azerbaigian 6
CL - Cile 6
JM - Giamaica 6
OM - Oman 6
AU - Australia 5
HN - Honduras 5
KE - Kenya 5
KR - Corea 5
NP - Nepal 5
PA - Panama 5
PH - Filippine 5
PT - Portogallo 5
AM - Armenia 4
BG - Bulgaria 4
DZ - Algeria 4
KZ - Kazakistan 4
MY - Malesia 4
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
GA - Gabon 3
HR - Croazia 3
HU - Ungheria 3
LV - Lettonia 3
NI - Nicaragua 3
RO - Romania 3
TH - Thailandia 3
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BZ - Belize 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
GY - Guiana 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 12.546
Salva come PNG Salva come JPEG
Città #
Dallas 2.628
Moscow 1.222
Singapore 510
Abidjan 339
Ashburn 266
New York 157
The Dalles 157
Hong Kong 149
Beijing 137
Los Angeles 110
Ho Chi Minh City 93
São Paulo 68
Amsterdam 44
Boardman 44
Hanoi 41
Brooklyn 38
Nuremberg 38
Santa Clara 38
Warsaw 37
Frankfurt am Main 34
Tokyo 32
Montreal 31
Assago 30
Denver 30
London 30
Munich 30
Chennai 29
Chicago 27
Dublin 27
Brno 26
Phoenix 24
San Francisco 24
Stockholm 24
Boston 23
Rio de Janeiro 22
Toronto 21
Johannesburg 20
Atlanta 16
Belo Horizonte 16
Ankara 15
Columbus 15
Mexico City 15
Council Bluffs 14
Da Nang 14
West Jordan 14
Baghdad 12
Helsinki 12
Ottawa 12
Brasília 11
Charlotte 11
Guarulhos 11
Haiphong 11
Houston 11
Poplar 11
Querétaro 11
Volta Redonda 11
Falkenstein 10
Orem 10
Brussels 9
Córdoba 9
Goiânia 9
Lahore 9
Mumbai 9
Rome 9
Tashkent 9
Vienna 9
Curitiba 8
Ha Long 8
Jakarta 8
Lappeenranta 8
Manchester 8
Santo André 8
Terzigno 8
Montevideo 7
New Delhi 7
Sumaré 7
Turku 7
Baku 6
Damietta 6
Guayaquil 6
Las Vegas 6
Milan 6
Orlando 6
Quito 6
Ribeirão Preto 6
Salvador 6
Seeb 6
São Bernardo do Campo 6
São José dos Campos 6
Vilnius 6
Acerra 5
Camaçari 5
Ezeiza 5
Fortaleza 5
Helena 5
Kingston 5
Lima 5
Naples 5
Olomouc 5
Porto Alegre 5
Totale 7.147
Salva come PNG Salva come JPEG
Nome #
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 589
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 521
A genic and epigenetic combination therapy for liver cancer 106
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 102
A suspected infective endocarditis in patients with a history of chronic HCV infection 101
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 100
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 95
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 93
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 92
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 90
Adherence to AISF recommendations for integrated management of hepatocellular carcinoma in a real–world clinical practice 90
Advances in Nanomedicine for Precision Insulin Delivery 90
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 89
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 88
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 87
[Next Generation Sequencing and ADPKD] 86
A gene and epigenetic combination therapy for liver cancer treatment 85
A clear case of portal hypertension: a logical consequence of liver cirrhosis? 82
. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics 81
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 81
An atypical resentation of a parasitic infection, simulating abdominal expansive mass: a multidisciplinary case report 80
An atypical presentation of a rare parasitic infection of Fasciola hepatica: a multidisciplinary case report. 80
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 80
Adherence to Barcelona Clinic Liver Cancer guidelines in field-practice: results of Progetto Epatocarcinoma Campania 80
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 79
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 79
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 79
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 79
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 78
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 77
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 77
Antibiotic use and associated factors in a large sample of hospitalised older people 77
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 76
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 73
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 73
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 73
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 71
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis 68
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 67
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 66
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 64
HCV-related steatosis and risk of atherosclerosis 63
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 62
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 61
Steatosis is a determinant of fibrosis progression in chronic hepatitis C and is correlated both with body composition and viral factors 61
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations 61
Cardiovascular benefits from gliflozins: Effects on endothelial function 60
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 60
Hepatocellular carcinoma and non alcoholic fatty liver disease; a dangerous liaison 60
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 56
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 54
What changed in the Italian internal medicine and geriatric wards during the lockdown 52
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 52
Liver fibrosis by FibroScan is highly prevalent in type 2 diabetic patients with NAFLD and fairly normal liver enzymes but increased uric acid 52
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 51
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 51
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 50
Epigenetic and Genetic Keys to Fight HPV-Related Cancers 47
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 47
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study. Authors’ reply 47
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 46
Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up? 46
Sonoporation by microbubbles as gene therapy approach for liver cancer 46
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 46
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 45
Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis 44
HCV-related steatosis and risk of atherosclerosis 44
Incidence of HCC recurrence after DAA treatment for HCV in a multicentre Italian cohort study 44
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 43
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 43
Insulin resistance and cancer: molecular links and clinical perspectives 43
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 43
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 42
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 42
Lactate in pleural and abdominal effusions 41
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 41
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 40
Early changes of liver stiffness in HCV patients undergoing treatment with direct-acting antivirals (DDAs): a multicenter study 39
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 39
Antioxidant diet and genotyping as tools for the prevention of liver disease 39
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis 39
Twelve-week course of pIFN-a-2a/ribavirin is an optimized regimen for treatment of HCV genotype 2 but not genotype 3 non-cirrhotic patients with RVR 39
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 39
Influence of antiviral therapy on liver stiffness evaluation in chronic hepatitis HBV patients in a real world setting: preliminary data in a multicentric study 38
The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology 38
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 38
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 37
Metformin: An old drug against old age and associated morbidities 37
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 37
Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments? 37
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 37
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management 37
L'indagine medico-nucleare dei tumori del pancreas endocrino 37
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 36
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 36
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 36
Editorial: Tissue resonance interaction method: a challenge for the early and non-invasive diagnosis of solid cancers 36
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 36
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 36
Transient elastography has a practical role in monitoring liver transplanted patients: preliminary results from experience in a real world setting 36
Totale 6.969
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.807
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024334 0 0 0 0 2 151 11 44 5 17 20 84
2024/20253.369 520 223 254 23 416 66 112 121 453 74 490 617
2025/20268.893 530 1.404 1.774 735 3.353 1.097 0 0 0 0 0 0
Totale 12.596